Our demonstration that SPARC, by potentiating ER stress signaling through its interaction with GRP78 to promote cell death following chemotherapy, may be another mechanism that likely contributed to the dramatic regressions of therapy-resistant CRC tumor xenografts following SPARC-based therapy in previous reports11,13. The gene discussed is HSPA5; the disease is colorectal carcinoma.